0,902  0,005  Antiinflammatory
0,858  0,009  Transcription factor NF kappa B inhibitor
0,851  0,011  Apoptosis agonist
0,815  0,004  Sensitization
0,769  0,015  Caspase 9 stimulant
0,750  0,002  TRPA1 agonist
0,749  0,008  Chemopreventive
0,713  0,007  Bone diseases treatment
0,710  0,017  Antineoplastic (lung cancer)
0,692  0,006  Nitric oxide antagonist
0,686  0,005  Antipyretic
0,691  0,022  Antineoplastic (breast cancer)
0,681  0,015  TNF expression inhibitor
0,680  0,016  Antineoplastic (colorectal cancer)
0,674  0,018  Teratogen
0,660  0,008  Antiosteoporotic
0,661  0,017  Antineoplastic (colon cancer)
0,618  0,021  Embryotoxic
0,606  0,009  Apoptosis antagonist
0,609  0,023  Antileukemic
0,594  0,011  Hepatic disorders treatment
0,580  0,002  Abortion inducer
0,593  0,020  Antibacterial
0,588  0,019  Respiratory analeptic
0,578  0,015  Antineoplastic (melanoma)
0,574  0,013  AR expression inhibitor
0,564  0,005  Hepatoprotectant
0,561  0,012  Antifungal
0,564  0,016  Mutagenic
0,543  0,002  Lipase inhibitor
0,540  0,008  Antineoplastic (lymphoma)
0,552  0,020  Immunosuppressant
0,541  0,016  Proliferative diseases treatment
0,539  0,015  Caspase 3 stimulant
0,536  0,014  Antineoplastic (multiple myeloma)
0,538  0,022  Antipruritic, allergic
0,531  0,019  Analeptic
0,525  0,021  Cytotoxic
0,519  0,019  Antineoplastic (pancreatic cancer)
0,507  0,018  Antineoplastic (glioma)
0,506  0,019  Antipsoriatic
0,501  0,032  Prostate cancer treatment
0,502  0,036  CYP2C9 substrate
0,462  0,007  Antiacne
0,482  0,030  Antineoplastic (ovarian cancer)
0,466  0,021  Antiprotozoal (Leishmania)
0,462  0,025  Antineoplastic (brain cancer)
0,440  0,003  Cholesterol synthesis inhibitor
0,441  0,006  Protein-tyrosine phosphatase inhibitor
0,448  0,028  Chemoprotective
0,424  0,009  Interferon gamma antagonist
0,461  0,048  CYP3A4 substrate
0,414  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,417  0,012  Non-steroidal antiinflammatory agent
0,414  0,010  Prostate disorders treatment
0,427  0,023  Antineoplastic (glioblastoma multiforme)
0,414  0,014  UGT1A4 substrate
0,426  0,031  ICAM1 expression inhibitor
0,427  0,032  NOS3 expression inhibitor
0,425  0,031  Antioxidant
0,411  0,019  Antineoplastic (endocrine cancer)
0,400  0,011  Hair growth stimulant
0,395  0,012  Prostatic (benign) hyperplasia treatment
0,416  0,038  CYP2C19 substrate
0,396  0,018  Sodium/bile acid cotransporter inhibitor
0,386  0,012  Antipruritic, non-allergic
0,398  0,032  NOS2 expression inhibitor
0,369  0,004  Alcohol dehydrogenase substrate
0,384  0,020  Eye irritation, high
0,384  0,022  Transcription factor STAT3 inhibitor
0,384  0,027  Antineoplastic (renal cancer)
0,379  0,023  Antiulcerative
0,369  0,020  UGT1A1 substrate
0,372  0,029  Antineoplastic (osteosarcoma)
0,356  0,017  UGT2B7 substrate
0,379  0,048  Antihypercholesterolemic
0,359  0,030  Angiogenesis stimulant
0,328  0,003  Aldehyde dehydrogenase substrate
0,378  0,056  Immunostimulant
0,350  0,034  Antineoplastic (liver cancer)
0,363  0,048  Lipoprotein disorders treatment
0,331  0,020  Contraceptive
0,395  0,094  Cyclophilin D inhibitor
0,395  0,094  Antidiabetic
0,394  0,095  Antiarthritic
0,341  0,046  UGT2B4 substrate
0,336  0,041  Hypoglycemic
0,335  0,042  Platelet antagonist
0,320  0,028  Growth hormone agonist
0,296  0,010  Aldose reductase substrate
0,328  0,042  Antidiabetic symptomatic
0,314  0,030  Platelet adhesion inhibitor
0,322  0,044  Transcription factor STAT inhibitor
0,341  0,067  Antithrombotic
0,319  0,051  Antihypoxic
0,293  0,025  Antialcoholic
0,268  0,003  Bile acid receptor antagonist
0,307  0,044  Carcinogenic
0,302  0,042  Antineoplastic (lymphocytic leukemia)
0,295  0,036  UDP-glucuronosyltransferase substrate
0,257  0,005  Transcription factor NF kappa B stimulant
0,256  0,004  Leukotriene synthesis inhibitor
0,271  0,026  Skin irritative effect
0,247  0,004  CDC25A inhibitor
0,252  0,011  Farnesoid X receptor antagonist
0,320  0,093  Stroke treatment
0,255  0,029  UGT1A3 substrate
0,230  0,010  Contraceptive female
0,246  0,026  Bone formation stimulant
0,231  0,011  Choleretic
0,249  0,034  Lipocortins synthesis antagonist
0,210  0,008  ABCA1 expression enhancer
0,212  0,017  Microtubule formation inhibitor
0,223  0,034  Antiviral (Influenza A)
0,227  0,038  Antiviral (Herpes)
0,191  0,002  Na+ K+ transporting ATPase inhibitor
0,244  0,059  Antihypertriglyceridemic
0,220  0,035  Succinate dehydrogenase inhibitor
0,207  0,027  Arachidonic acid antagonist
0,214  0,036  Melanin inhibitor
0,262  0,085  Radioprotector
0,208  0,032  UGT2B10 substrate
0,180  0,005  CDC25B inhibitor
0,210  0,037  Phospholipase A2 inhibitor
0,255  0,085  Renal disease treatment
0,227  0,058  Antiviral (Influenza)
0,186  0,021  Adenylate cyclase stimulant
0,178  0,013  Actinic keratosis treatment
0,222  0,057  Neurotrophic factor enhancer
0,229  0,065  Antineoplastic enhancer
0,238  0,075  DNA synthesis inhibitor
0,252  0,089  Antidiabetic (type 2)
0,171  0,009  Antiviral (Coronavirus)
0,171  0,009  Antiviral (SARS coronavirus)
0,276  0,117  Calcium channel activator
0,193  0,034  Antifungal enhancer
0,162  0,005  Hypercalcemia treatment
0,162  0,006  5-Alpha-reductase inhibitor
0,165  0,019  Antispirochetal
0,169  0,027  Antineoplastic antibiotic
0,155  0,015  Anabolic
0,226  0,087  Cardiovascular analeptic
0,177  0,043  Skin whitener
0,172  0,038  DNA polymerase I inhibitor
0,219  0,089  Antineoplastic (cervical cancer)
0,177  0,050  Antineoplastic (squamous cell carcinoma)
0,146  0,020  Factor V inhibitor
0,220  0,094  Antineoplastic (non-small cell lung cancer)
0,233  0,107  Cardioprotectant
0,137  0,013  3C-Like protease (SARS coronavirus) inhibitor
0,218  0,096  Vascular (periferal) disease treatment
0,181  0,060  Antineoplastic (bone cancer)
0,154  0,034  Vanilloid 1 agonist
0,183  0,065  Dual specificity phosphatase inhibitor
0,134  0,017  Ornithine decarboxylase inhibitor
0,142  0,025  Androgen antagonist
0,235  0,125  CTGF expression inhibitor
0,133  0,024  UGT2B11 substrate
0,178  0,069  Antirickettsial
0,203  0,095  Antiglaucomic
0,205  0,105  Tumour necrosis factor alpha release inhibitor
0,106  0,006  Heme oxygenase stimulant
0,229  0,139  Angiogenesis inhibitor
0,094  0,007  Postcoital contraceptive
0,098  0,012  Prostaglandin F2 alpha antagonist
0,089  0,004  Parathyroid hormone antagonist
0,155  0,072  UGT2B9 substrate
0,140  0,057  Antihemorrhagic
0,204  0,122  UGT1A9 substrate
0,083  0,004  ATP citrate lysase inhibitor
0,099  0,024  Ca(v)3.1 blocker
0,112  0,037  Paget's disease treatment
0,140  0,066  Antieczematic
0,106  0,032  Antibiotic
0,102  0,029  Keratolytic
0,223  0,152  Interleukin 2 agonist
0,165  0,094  Antihelmintic
0,140  0,077  Antineoplastic (carcinoma)
0,070  0,010  Retinoid X receptor agonist
0,153  0,094  Dual specificity phosphatase 3 inhibitor
0,062  0,004  Vitamin D receptor antagonist
0,085  0,029  Hyperparathyroidism treatment
0,172  0,116  Hypolipemic
0,220  0,166  GST A substrate
0,056  0,005  Retinoid X gamma receptor agonist
0,062  0,011  Retinoid X alpha receptor agonist
0,052  0,003  Progesterone receptor B antagonist
0,068  0,024  Lipocortins synthesis agonist
0,141  0,098  Uterine stimulant
0,106  0,063  UGT2B1 substrate
0,068  0,025  Protein 50S ribosomal subunit inhibitor
0,142  0,102  Interleukin 6 antagonist
0,043  0,005  Retinoid X beta receptor agonist
0,049  0,014  Retinoid X receptor antagonist
0,158  0,124  Antiparasitic
0,038  0,005  Retinoid X gamma receptor antagonist
0,080  0,048  Narcotic antagonist
0,224  0,193  Atherosclerosis treatment
0,048  0,017  GABA uptake inhibitor
0,042  0,013  Retinoid X alpha receptor antagonist
0,053  0,024  Microtubule stabilization
0,071  0,045  Anticholelithogenic
0,091  0,065  Antiviral (Rhinovirus)
0,044  0,020  Retinoic acid alpha receptor agonist
0,029  0,005  Retinoid X beta receptor antagonist
0,064  0,040  Antimycoplasmal
0,064  0,040  Caspase 9 inhibitor
0,108  0,085  Growth stimulant
0,193  0,171  Cholesterol antagonist
0,028  0,008  Retinoic acid gamma receptor agonist
0,030  0,010  CYP24 inhibitor
0,035  0,016  Prostaglandin D2 agonist
0,037  0,018  RNA-directed RNA polymerase stimulant
0,054  0,038  Postmenopausal disorders treatment
0,082  0,065  Vanilloid agonist
0,027  0,012  Retinoic acid receptor agonist
0,163  0,147  Myocardial infarction treatment
0,041  0,026  Membrane dipeptidase inhibitor
0,021  0,006  Vitamin D receptor agonist
0,114  0,099  Protein kinase stimulant
0,090  0,077  Glutathione S-transferase substrate
0,079  0,066  Thioredoxin reductase inhibitor
0,022  0,011  Retinoic acid beta receptor agonist
0,125  0,115  Antifungal (Cryptococcus)
0,138  0,129  LDLR expression enhancer
0,160  0,151  VCAM1 expression inhibitor
0,021  0,014  Retinoic acid alpha receptor antagonist
0,061  0,055  Phosphofructokinase-1 inhibitor
0,032  0,028  HMG CoA reductase inhibitor
0,065  0,060  SULT2A1 substrate
0,020  0,016  Corticosteroid-like
0,012  0,009  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,099  0,097  Amylase inhibitor
0,091  0,089  Antiinfertility, female
0,035  0,033  Glucose-6-phosphate dehydrogenase inhibitor
0,053  0,051  Androgen agonist
0,017  0,015  Retinoic acid receptor antagonist
0,074  0,073  Inducible nitric-oxide synthase inhibitor
0,021  0,019  Prostaglandin F2 alpha agonist
0,004  0,003  Vitamin D-like
0,049  0,049  Aromatase inhibitor

